Provided by Tiger Trade Technology Pte. Ltd.

TG Therapeutics

54.30
+0.37000.69%
Post-market: 54.310.0100+0.02%19:58 EDT
Volume:1.62M
Turnover:87.45M
Market Cap:8.31B
PE:19.61
High:54.36
Open:53.58
Low:52.67
Close:53.93
52wk High:59.30
52wk Low:26.76
Shares:153.09M
Float Shares:141.54M
Volume Ratio:1.01
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.77
EPS(LYR):2.77
ROE:100.28%
ROA:7.28%
PB:13.76
PE(LYR):19.60

Loading ...

Design Therapeutics Q2 Net Loss Narrower than Expected

Reuters
·
Aug 03

Movement Alert|TG Therapeutics Falls 5.37% in Pre-Market Trading, Q2 EPS Misses Estimates by 85%

Market Focus
·
Aug 03

Stock Track | TG Therapeutics (TGTX) Plunges 5.37% in Pre-market After Q2 Earnings Miss, Despite Strong Revenue and Raised Guidance

Stock Track
·
Aug 03

Ocular Therapeutix Q2 Product Revenue Flat, Net Loss Widens on Higher Spending

Reuters
·
Aug 03

TG Therapeutics Q2 Product Revenue Rises 70% on Briumvi Sales

Reuters
·
Aug 03

Earnings Flash (TGTX) TG Therapeutics Posts Q2 EPS $0.05, vs. FactSet Est of $0.31

MT Newswires Live
·
Aug 03

TG Therapeutics Q2 Net Income Drops to $7.8 Million; Revenue Rises 70.26% to $240.3 Million

Reuters
·
Aug 03

TG Therapeutics Q2 EPS $0.05 Misses $0.33 Estimate, Sales $240.335M Beat $229.721M Estimate

Benzinga Earnings
·
Aug 03

TG Therapeutics Q2 EPS USD 0.05

THOMSON REUTERS
·
Aug 03

TG Therapeutics - Raises FY 2026 Total Global Revenue Target to About $950 Mln

THOMSON REUTERS
·
Aug 03

TG Therapeutics Q2 Operating Income USD 21.674 Million

THOMSON REUTERS
·
Aug 03

TG Therapeutics Reports Second Quarter 2026 Financial Results and Raises BRIUMVI® Revenue Guidance

GlobeNewswire
·
Aug 03

TG Therapeutics is Maintained at Buy by B. Riley Securities

Dow Jones
·
Jul 28

B. Riley Raises Price Target on TG Therapeutics to $86 From $55, Keeps Buy Rating

MT Newswires Live
·
Jul 27

TG Therapeutics Inc : B. Riley Raises Target Price to $86 from $55

THOMSON REUTERS
·
Jul 27

Analyst Tara Bancroft Raises TG Therapeutics Price Target to $75 on Strong Long-Term Briumvi Growth Outlook

TIPRANKS
·
Jul 22

Analysts Offer Insights on Healthcare Companies: Travere Therapeutics (TVTX), McKesson (MCK) and TG Therapeutics (TGTX)

TIPRANKS
·
Jul 22

TG Therapeutics Targets Myasthenia Gravis Growth With New BRIUMVI Trial

TIPRANKS
·
Jul 18

Analysts’ Opinions Are Mixed on These Healthcare Stocks: TG Therapeutics (TGTX), Protagonist Therapeutics (PTGX) and PROCEPT BioRobotics (PRCT)

TIPRANKS
·
Jul 16

Analysts Conflicted on These Healthcare Names: Biogen (BIIB) and TG Therapeutics (TGTX)

TIPRANKS
·
Jul 14